{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:39:23Z","timestamp":1793065163995,"version":"4.5.0"},"reference-count":38,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Acquired somatic mutations are crucial for the development of most cancers. We performed a comprehensive comparative analysis of the mutational landscapes and their correlation with CHIP-related (clonal hematopoiesis of indeterminate potential) mutations and patient age of 122 genes in 3096 cases of 28 different hematological malignancies. Differences were observed regarding (1) the median number of mutations (highest, median n = 4; lowest, n = 0); (2) specificity of certain mutations (high frequencies in atypical chronic myeloid leukemia [aCML; ASXL1, 86%], follicular lymphoma [FL; KMT2D, 87%; CREBBP, 73%], hairy cell lymphoma [BRAF, 100%], lymphoplasmacytic lymphoma [MYD88, 98%; CXCR4, 51%], myeloproliferative neoplasm [MPN; AK2, 68%]); (3) distribution of mutations (broad distribution within\/across the myeloid\/lymphoid lineage for TET2, ASXL1, DNMT3A, TP53, BCOR, and ETV6); (4) correlation of mutations with patient\u2019s age (correlated with older age across entities: TET2, DNMT3A, ASXL1, TP53, EZH2, BCOR, GATA2, and IDH2; younger age: KIT, POT1, RAD21, U2AF2, and WT1); (5) correlation of mutation number per patient with age. Moreover, we observed high frequencies of mutations in RUNX1, SRSF2, IDH2, NRAS, and EZH2 in cases comprising at least 1 DTA (DNMT3A, TET2, ASXL1) mutation, whereas in cases without DTA mutations, TP53, KRAS, WT1, and SF3B1 were more frequent across entities, suggesting differences in pathophysiology. These results give further insight into the complex genetic landscape and the role of DTA mutations in hematological neoplasms and define mutation-driven entities (myelodysplastic syndrome\/MPN overlap; secondary acute myeloid) in comparison with entities defined by chromosomal fusions (chronic myeloid leukemia; myeloid\/lymphoid neoplasm with eosinophilia).<\/jats:p>","DOI":"10.1182\/bloodadvances.2021004668","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T16:33:03Z","timestamp":1632760383000},"page":"4426-4434","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":60,"title":["Mutational patterns and their correlation to CHIP-related mutations and age in hematological malignancies"],"prefix":"10.1182","volume":"5","author":[{"given":"Anna","family":"Stengel","sequence":"first","affiliation":[{"name":"MLL Munich Leukemia Laboratory, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"Baer","sequence":"additional","affiliation":[{"name":"MLL Munich Leukemia Laboratory, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5083-9838","authenticated-orcid":false,"given":"Wencke","family":"Walter","sequence":"additional","affiliation":[{"name":"MLL Munich Leukemia Laboratory, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manja","family":"Meggendorfer","sequence":"additional","affiliation":[{"name":"MLL Munich Leukemia Laboratory, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Kern","sequence":"additional","affiliation":[{"name":"MLL Munich Leukemia Laboratory, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Haferlach","sequence":"additional","affiliation":[{"name":"MLL Munich Leukemia Laboratory, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Haferlach","sequence":"additional","affiliation":[{"name":"MLL Munich Leukemia Laboratory, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,11,2]]},"reference":[{"issue":"3","key":"2021110215243391100_B1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/carcin\/21.3.379","article-title":"Significance of multiple mutations in cancer","volume":"21","author":"Loeb","year":"2000","journal-title":"Carcinogenesis."},{"issue":"6673","key":"2021110215243391100_B2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/32520","article-title":"A checkpoint on the road to cancer","volume":"392","author":"Orr-Weaver","year":"1998","journal-title":"Nature."},{"issue":"15","key":"2021110215243391100_B3","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMra023001","article-title":"Acute lymphoblastic leukemia","volume":"350","author":"Pui","year":"2004","journal-title":"N Engl J Med."},{"key":"2021110215243391100_B4","volume-title":"WHO classification of tumours of haematopoetic and lymphoid tissue","author":"Swerdlow","year":"2017","edition":"Revised 4th Ed"},{"issue":"24","key":"2021110215243391100_B5","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","article-title":"BRAF mutations in hairy-cell leukemia","volume":"364","author":"Tiacci","year":"2011","journal-title":"N Engl J Med."},{"issue":"13","key":"2021110215243391100_B6","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1182\/blood-2012-09-457101","article-title":"Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom\u2019s macroglobulinemia and related lymphoid neoplasms","volume":"121","author":"Varettoni","year":"2013","journal-title":"Blood."},{"issue":"1-2","key":"2021110215243391100_B7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mrrev.2011.05.001","article-title":"A review and appraisal of the DNA damage theory of ageing","volume":"728","author":"Freitas","year":"2011","journal-title":"Mutat Res."},{"issue":"1","key":"2021110215243391100_B8","doi-asserted-by":"crossref","first-page":"e1007108","DOI":"10.1371\/journal.pgen.1007108","article-title":"Aging and the rise of somatic cancer-associated mutations in normal tissues","volume":"14","author":"Risques","year":"2018","journal-title":"PLoS Genet."},{"issue":"1","key":"2021110215243391100_B9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood."},{"issue":"26","key":"2021110215243391100_B10","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med."},{"issue":"25","key":"2021110215243391100_B11","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1182\/blood-2017-01-763425","article-title":"Clinical significance of somatic mutation in unexplained blood cytopenia","volume":"129","author":"Malcovati","year":"2017","journal-title":"Blood."},{"issue":"9","key":"2021110215243391100_B12","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/stem.2845","article-title":"Concise review: age-related clonal hematopoiesis: stem cells tempting the devil","volume":"36","author":"Busque","year":"2018","journal-title":"Stem Cells."},{"issue":"2","key":"2021110215243391100_B13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med."},{"issue":"1","key":"2021110215243391100_B14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(16)30626-X","article-title":"Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study","volume":"18","author":"Takahashi","year":"2017","journal-title":"Lancet Oncol."},{"issue":"1","key":"2021110215243391100_B15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/sj.leu.2402329","article-title":"Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases","volume":"16","author":"Schoch","year":"2002","journal-title":"Leukemia."},{"issue":"2","key":"2021110215243391100_B16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1200\/JCO.2003.08.005","article-title":"Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies","volume":"21","author":"Haferlach","year":"2003","journal-title":"J Clin Oncol."},{"issue":"10","key":"2021110215243391100_B17","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1182\/blood-2004-03-1036","article-title":"Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia","volume":"104","author":"Kern","year":"2004","journal-title":"Blood."},{"issue":"1","key":"2021110215243391100_B18","doi-asserted-by":"crossref","first-page":"160025","DOI":"10.1038\/sdata.2016.25","article-title":"Extensive sequencing of seven human genomes to characterize benchmark reference materials","volume":"3","author":"Zook","year":"2016","journal-title":"Sci Data."},{"issue":"4","key":"2021110215243391100_B19","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/humu.22033","article-title":"Detecting false-positive signals in exome sequencing","volume":"33","author":"Fuentes Fajardo","year":"2012","journal-title":"Hum Mutat."},{"issue":"7809","key":"2021110215243391100_B20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans [published correction appears in Nature. 2021;590(7846):E53]","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature."},{"issue":"D1","key":"2021110215243391100_B21","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"2021110215243391100_B22","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2019-128488","article-title":"A novel machine learning based in silico pathogenicity predictor for missense variants in a hematological setting [abstract]","volume":"134","author":"Hutter","year":"2019","journal-title":"Blood."},{"issue":"4","key":"2021110215243391100_B23","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/ajcp\/103.4.472","article-title":"Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t(14; 18) in follicular lymphoma","volume":"103","author":"H","year":"1995","journal-title":"Am J Clin Pathol."},{"issue":"5","key":"2021110215243391100_B24","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1200\/JCO.1988.6.5.919","article-title":"Chromosome studies in the non-Hodgkin\u2019s lymphomas: the role of the 14;18 translocation","volume":"6","author":"Rowley","year":"1988","journal-title":"J Clin Oncol."},{"issue":"6","key":"2021110215243391100_B25","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/ijc.10975","article-title":"BCL-2\/JH translocation in peripheral blood lymphocytes of unexposed individuals: lack of seasonal variations in frequency and molecular features","volume":"104","author":"Roulland","year":"2003","journal-title":"Int J Cancer."},{"issue":"6","key":"2021110215243391100_B26","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.leukres.2005.10.001","article-title":"The bcl-2\/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity","volume":"30","author":"Schmitt","year":"2006","journal-title":"Leuk Res."},{"issue":"10","key":"2021110215243391100_B27","doi-asserted-by":"crossref","first-page":"E1116","DOI":"10.1073\/pnas.1501199112","article-title":"Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation","volume":"112","author":"Green","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"issue":"20","key":"2021110215243391100_B28","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood."},{"issue":"10","key":"2021110215243391100_B29","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2017-03-776674","article-title":"Absence of driver mutations in persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes","volume":"130","author":"Tesson","year":"2017","journal-title":"Blood."},{"issue":"8","key":"2021110215243391100_B30","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1038\/s41375-018-0030-3","article-title":"Prognostic significance of interphase FISH in monoclonal gammopathy of undetermined significance","volume":"32","author":"Lakshman","year":"2018","journal-title":"Leukemia."},{"key":"2021110215243391100_B31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3389\/fonc.2019.00229","article-title":"Basket trials for intractable cancer","volume":"9","author":"Qin","year":"2019","journal-title":"Front Oncol."},{"key":"2021110215243391100_B32","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.2506","article-title":"Results from the biomarker-driven basket trial of RO5126766 (CH5127566), a potent RAF\/MEK inhibitor, in RAS- or RAF-mutated malignancies including multiple myeloma [abstract]","volume":"35","author":"Chenard-Poirier","year":"2017","journal-title":"J Clin Oncol."},{"key":"2021110215243391100_B33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejca.2020.06.023","article-title":"KRAS inhibition in non-small cell lung cancer: past failures, new findings and upcoming challenges","volume":"137","author":"Passiglia","year":"2020","journal-title":"Eur J Cancer."},{"issue":"10","key":"2021110215243391100_B34","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1007\/s00535-020-01712-9","article-title":"Systemic treatment options for advanced biliary tract carcinoma","volume":"55","author":"Xie","year":"2020","journal-title":"J Gastroenterol."},{"issue":"5","key":"2021110215243391100_B35","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3324\/haematol.2017.177212","article-title":"Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations","volume":"103","author":"Agathangelidis","year":"2018","journal-title":"Haematologica."},{"issue":"4","key":"2021110215243391100_B36","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ng.542","article-title":"PHF6 mutations in T-cell acute lymphoblastic leukemia","volume":"42","author":"Van Vlierberghe","year":"2010","journal-title":"Nat Genet."},{"issue":"8","key":"2021110215243391100_B37","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.modgep.2007.06.007","article-title":"Protein and gene expression analysis of Phf6, the gene mutated in the B\u00f6rjeson-Forssman-Lehmann Syndrome of intellectual disability and obesity","volume":"7","author":"Voss","year":"2007","journal-title":"Gene Expr Patterns."},{"issue":"1","key":"2021110215243391100_B38","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/leu.2010.247","article-title":"PHF6 mutations in adult acute myeloid leukemia","volume":"25","author":"Van Vlierberghe","year":"2011","journal-title":"Leukemia."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/21\/4426\/1832103\/advancesadv2021004668.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/21\/4426\/1832103\/advancesadv2021004668.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T20:36:53Z","timestamp":1635885413000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/5\/21\/4426\/477035\/Mutational-patterns-and-their-correlation-to-CHIP"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,2]]},"references-count":38,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2021,11,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021004668","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,2]]}}}